| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/17/2006 | CN1772143A Gout treating medicine |
| 05/17/2006 | CN1772136A Medicine composition for treating soft tissue damage and osteoarthropathy and its prepn process |
| 05/17/2006 | CN1772135A Spur eliminating antiphlogistic plaster and its prepn |
| 05/17/2006 | CN1772130A Gukang dripping pill for treating fracture and its prepn |
| 05/17/2006 | CN1772111A Medicinal wine for treating rheumatism and rheumatoid disease and its prepn |
| 05/17/2006 | CN1772067A Medicine for treating rheumarthritis |
| 05/17/2006 | CN1772058A Cervical spondylosis treating Chinese medicine |
| 05/17/2006 | CN1772056A Chinese medicine prepn for dispelling wind evil and relieving pain and its prepn process |
| 05/17/2006 | CN1772051A Soft tissue injury treating tablet and its prepn |
| 05/17/2006 | CN1772048A Medicine oil for relaxing joints and its prepn |
| 05/17/2006 | CN1772047A Recipe of plaster for treating cervical vertebra and lumber vertebra arthritis |
| 05/17/2006 | CN1772046A Hyperosteogeny treating medicine |
| 05/17/2006 | CN1772045A Rheumatism treating medicine |
| 05/17/2006 | CN1772033A Use of cajan seed and its extract in preparing medicine for treating osteal arthritis |
| 05/17/2006 | CN1772015A Cervical spondylosis treating medicine and its prepn |
| 05/17/2006 | CN1771986A Orally taken joint function protectant |
| 05/17/2006 | CN1771973A Composite medicine containing nonsteroidal anti-inflammatory analgetic and its prepn |
| 05/17/2006 | CN1771972A Clodronate liposome and its prepn |
| 05/17/2006 | CN1771962A Piroxicam dripping pill and its prepn |
| 05/17/2006 | CN1771941A Leflunomide dripping pill and its prepn |
| 05/17/2006 | CN1771939A Indomethacin dripping pill and its prepn |
| 05/17/2006 | CN1771934A Medicine composite containing red clover prime and prunetin and its medicinal application |
| 05/17/2006 | CN1256342C Acetamido glucose devicative of indomethacin and its synthetic method and use |
| 05/17/2006 | CN1256134C Medicinal composition for treating rheumatoid |
| 05/17/2006 | CN1256127C Chinese patent medicine for injury of muscle and joint and its preparation |
| 05/17/2006 | CN1256115C Externally applied plaster for treating knee-joint pain caused by wind dampness |
| 05/17/2006 | CN1256110C Chinese medicine for expelling stasis |
| 05/17/2006 | CN1256102C Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation |
| 05/17/2006 | CN1256099C Application of ivory powder for curing bone tuberculosis and osteomyelitis |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045614 LIM mineralization protein splice variants |
| 05/16/2006 | US7045540 Selective estrogen receptor modulators |
| 05/16/2006 | US7045539 Therapeutic benzoxazole compounds |
| 05/16/2006 | US7045534 Methods of reducing angiogenesis |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045116 Treatment of osteomyelitis with radiopharmaceuticals |
| 05/16/2006 | CA2171276C Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound |
| 05/11/2006 | WO2006050314A2 Once a day formulation for phosphate binders |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048884A1 Therapeutic treatment of accelerated bone resorption |
| 05/11/2006 | WO2006048473A1 β-LACTAMIC RGD CYCLOPEPTIDES CONTAINING GAMMA (Ϝ) TURNS |
| 05/11/2006 | WO2006048329A1 Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent |
| 05/11/2006 | WO2006048251A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/11/2006 | US20060100431 Biologically active compounds |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060100150 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | US20060099691 Production of complex carbohydrates |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099186 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 05/11/2006 | US20060099182 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | DE102004054054A1 Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2586845A1 Therapeutic treatment of accelerated bone resorption |
| 05/11/2006 | CA2586271A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2586021A1 Once a day formulation for phosphate binders |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655295A1 Anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/10/2006 | EP1654237A1 2-aminopyrimidine derivatives |
| 05/10/2006 | EP1654219A2 Hydrazide derivatives as prostaglandin receptors modulators |
| 05/10/2006 | EP1653994A2 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 05/10/2006 | EP1653993A1 Use of chemokines, and pharmaceutical preparations containing the same |
| 05/10/2006 | EP1653970A2 Gsk-3 inhibitors and uses thereof |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653940A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor |
| 05/10/2006 | EP1432991A4 Identification and isolation of somatic stem cells and uses thereof |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | EP1145001B1 (in vitro) model for gastrointestinal inflammation |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771226A 2-propylidene-19-nor-vitamin d compounds |
| 05/10/2006 | CN1771047A Pharmaceutical composition for prevention and treatment of osteoporosis and its preparation |
| 05/10/2006 | CN1771046A Preventive or remedy for arthritis |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1768832A Medicinal wine for treating injuries and falls, waist and leg pain |
| 05/10/2006 | CN1768818A Externally applied plaster for treating Bi syndrome and preparation method thereof |
| 05/10/2006 | CN1768817A Medicine for treating postpartum pathogenic-wind affection |
| 05/10/2006 | CN1768791A Chinese medicinal formulation for stopping pain for removing Bi |